Clinical Trial Update: This Randomized Controlled Trial Evaluates the Comparative Efficacy of Intravenous Meropenem Alone Versus Intravenous Meropenem Combined With Oral Azithromycin in Children Aged 6 Months to Under 5 Years Diagnosed With Blood Culture-confirmed Extensively Drug-resistant Uncomplicated Typhoid Fever [Phase 4]

View source ↗

Summary

Phase 4 randomized trial evaluating whether adding oral azithromycin to intravenous meropenem improves outcomes versus meropenem alone in children aged 6 months…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensively Drug-resistant Typhoid Fever
• Salmonella Typhi Infection
• Typhoid Fever

Drugs mentioned

• Azithromycin (azithromycin)
• Meropenem (Meropenem)

Snippet

Sponsor: Sheikh Zayed Medical College | Conditions: Extensively Drug-Resistant Typhoid Fever, Typhoid Fever | Phase 4 | Status: COMPLETED